**INTRODUCTION:** Autologus fat grafting is becoming widely used for breast reconstruction. However, the bioactive adipose stromal cells have been shown in many in vitro and animal studies to promote cancer cell growth. We report a new animal model that accurately simulates the clinical scenario of reconstructive fat grafting.

**METHODS:** 40 female NOD-SCID gamma mice were injected with 1K MCF7 breast cancer cells in 4 sites of mammary fat pads. After tumor engraftment in 2 weeks, injections of human lipoaspirate prepared according to Coleman's technique (N=20) or sterile saline (N=20, control) were performed at tumor sites. In 8 weeks, animals were euthanized and necropsied, tumor volume and mass were measured, and histological samples were assessed for presence of tumors, Nottingham histological grade, Ki67 positivity and metastatic spread.

**RESULTS:** In 8 weeks, all sites injected with breast cancer cells formed macroscopic tumors and all fat grafts were retained and colocated with breast cancer. Tumors from animals in the lipo group did not grow faster (p=0.54); and had lower volume (p=0.046) and lower mass (p=0.038) compared to saline group. Macroscopic invasion detected in necropsy was higher in saline group (p=0.003). Proliferation index assessed by Ki67 positivity was significantly lower in lipo group (p=0.01). No metastatic lesion was identified in lung, liver or spleen of any animal.

**CONCLUSION:** Reconstructive fat grafting performed in the setting of residual breast tumor in a clinically relevant animal model does not increase tumor size, mass, proliferation or metastatic spread. This supports the oncologic safety of fat grafting for breast reconstruction after cancer therapy.
